Disappointing market action.  

At $3.37, we are actually below where we closed March end.  Nor was the volume anything to write home about...at 149,000 shares, we were just a shade over the average 134,000 shares over the last 12 months.

What this suggests to me is that there are few people who are following this company (outside this group of course).  We need a major marketing effort to spread the good word.  I hope the Big Pharma companies are following this (which RVX insists they are)...but still, we should have gone to $4 today.  I sure hope this is not a sign of things to come!